Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Gruenenthal licenses urinary incontinence product to KeyNeurotek

March 6, 2007

NX-1207 completes long-term follow-up study in BPH

March 5, 2007

Vaprisol approved for treatment of hypervolemic hyponatremia

March 2, 2007

Plethora plans phase III program for Invicorp in erectile dysfunction

Feb. 28, 2007

New treatment option for urological disorders reported by Takeda

Feb. 28, 2007

Fosrenol launched in U.K.

Feb. 23, 2007

Ability of N-acetylcysteine to prevent acute renal failure in hypotensives unclear

Feb. 19, 2007

New treatment option for urological disorders disclosed in recent Ranbaxy patent

Feb. 15, 2007

Phase II trial of phosphate binder ILY-101 completes enrollment

Feb. 9, 2007

NX-1207 attracts licensing offers

Feb. 5, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Medtronic bolsters pain portfolio in $650M SPR Therapeutics buy
BioWorld
Medtronic plc is strengthening its pain management portfolio with its $650 million move to buy SPR Therapeutics Inc. and bring the company’s peripheral nerve...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...